Cholangiocarcinoma

Open Access
Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma
ERGİN AYDEMİR, FUNDA YILMAZ, ALPER TÜRKEL, ÖZTÜRK ATEŞ and MUTLU DOĞAN

In Vivo September 2025, 39 (5) 2976-2985; DOI: https://doi.org/10.21873/invivo.14098
Open Access
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo
PRIN SUNGWAN, SONEXAI KIDOIKHAMMOUAN, UNCHALEE THONSRI, CHARUPONG SAENGBOONMEE, SOPIT WONGKHAM, SEIJI OKADA and WUNCHANA SEUBWAI

In Vivo September 2024, 38 (5) 2284-2293; DOI: https://doi.org/10.21873/invivo.13693
Open Access
FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells
KIMYEUN OEURN, APINYA JUSAKUL, RATTANAPORN JAIDEE, VEERAPOL KUKONGVIRIYAPAN, LADDAWAN SENGGUNPRAI, AUEMDUAN PRAWAN and SARINYA KONGPETCH

In Vivo July 2023, 37 (4) 1628-1637; DOI: https://doi.org/10.21873/invivo.13248
Open Access
Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression
PAPITCHAYA SIRITHAWAT, APINYA JUSAKUL, SARINYA KONGPETCH, MALINEE THANEE, PEERADA SRICHANCHARA, SUPARADA PANJAROENSAK, PHONGSARAN KIMAWAHA, SUTTHIWAN JANTHAMALA, CHAIWAT APHIVATANASIRI and ANCHALEE TECHASEN

In Vivo July 2023, 37 (4) 1638-1648; DOI: https://doi.org/10.21873/invivo.13249
Open Access
Flavokawain B Inhibits Growth of Cholangiocarcinoma Cells by Suppressing the Akt Pathway
JUN HYUK SON, YOUNG HOON CHOI, SANG HYUB LEE, WOO HYUN PAIK, JI KON RYU and YONG-TAE KIM

In Vivo May 2023, 37 (3) 1077-1084; DOI: https://doi.org/10.21873/invivo.13182
Open Access
Development of a Prognostic Score for Cholangiocarcinoma Patients Using a Combination of Biochemical Parameters
HTET HTET MIN-OO, TIN MAY AUNG, MOLIN WONGWATTANAKUL, PORNSUDA MARAMING, TANAKORN PROUNGVITAYA and SIRIPORN PROUNGVITAYA

In Vivo May 2023, 37 (3) 1145-1155; DOI: https://doi.org/10.21873/invivo.13189
Open Access
3D Silk Fibroin-Gelatin/Hyaluronic Acid/Heparan Sulfate Scaffold Enhances Expression of Stemness and EMT Markers in Cholangiocarcinoma
ONANONG BUHOME, MOLIN WONGWATTANAKUL, JUREERUT DADUANG and TEMDUANG LIMPAIBOON

In Vivo May 2022, 36 (3) 1155-1167; DOI: https://doi.org/10.21873/invivo.12815
You have access
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma
UBONRAT THAMRONGWARANGGOON, SAKKARN SANGKHAMANON, WUNCHANA SEUBWAI, PAKSIREE SARANARUK, UBON CHA’ON and SOPIT WONGKHAM

In Vivo January 2021, 35 (1) 267-274; DOI: https://doi.org/10.21873/invivo.12255
You have access
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis
ALESSANDRO RIZZO, ANGELA DALIA RICCI, GIORGIO FREGA, ANDREA PALLONI, STEFANIA DE LORENZO, FRANCESCA ABBATI, VERONICA MOLLICA, SIMONA TAVOLARI, MARIACRISTINA DI MARCO and GIOVANNI BRANDI

In Vivo July 2020, 34 (4) 1701-1714; DOI: https://doi.org/10.21873/invivo.11964
You have access
In Vivo Study of Natural Killer (NK) Cell Cytotoxicity Against Cholangiocarcinoma in a Nude Mouse Model
IN HYE JUNG, DO HEE KIM, DA KYUNG YOO, SUN YOUNG BAEK, SEONG HOON JEONG, DAWOON E. JUNG, SEUNG WOO PARK and YONG-YOON CHUNG

In Vivo July 2018, 32 (4) 771-781; DOI: https://doi.org/10.21873/invivo.11307

Main menu

User menu

Search

Cholangiocarcinoma

Pages